HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever

Acta Tropica

Volumn 112, Issue 2, 2009, Pages 193-197

  Falcón Lezama, Jorge Abelardo ^a   Ramos, Celso ^a   Zuñiga, Joaquín ^b   Juárez Palma, Lilia ^a   Rangel Flores, Hilda ^a   García Trejo, Alma Rosa ^a   Acunha Alonzo, Victor ^c   Granados, Julio ^d   Vargas Alarcón, Gilberto ^e  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c National School of Anthropology and History   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Dengue; Genetic susceptibility; HLA; Mexican Mestizo; Polymorphisms

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; DENGUE FEVER; DISEASE SEVERITY; GENETIC ANALYSIS; GENOTYPE; HISTOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM; SYMPTOM; VIRUS;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISPANIC; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MEXICO; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POPULATION GENETICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DENGUE; FEMALE; GENE FREQUENCY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

MEXICO [NORTH AMERICA]; MORELOS; NORTH AMERICA;

DENGUE VIRUS;

EID: 70249111430     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.07.025     Document Type: Article

References (33)

1. Bethell D., Flobbe K., Phuong C., Day P., Phuong P., Buurman W., Cardosa M.J., White N.J., and Kwiatkowski D. Pathophysiology and prognostic role of cytokines in dengue hemorrhagic fever. J. Infect. Dis. 177 (1998) 778-782
2. Blackwell J.M., Goswami T., Evans C.A.W., Sibthorpe D., Papo N., White J.K., Searle S., Miller E.N., Peacock C.S., Mohammed H., and Ibrahim M. SLC11A1 (formerly NRAMP1) and disease resistance. Cell. Microbiol. 3 (2001) 773-784
3. Carrington M., Nelson G.W., Martin M.P., Kissner T., Vlahov D., Goedert J.J., Kaslow R., Buchbinder S., Hoots K., and O'Brien S.G. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283 (1999) 1748-1752
4. Chiewsilp P., McNair R., and Bhamarapravati N. Histocompatibility antigens and dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 30 (1981) 1100-1105
5. Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., Green S., Ennis F.A., Rothman A.L., and Libraty D.H. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J. Infect. Dis. 189 (2004) 990-1000
6. Fernández-Mestre M.T., Gendzekhadze K., Rivas-Vetencourt P., and Layrisse Z. TNF-α-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64 (2004) 469-472
7. Gambelunghe G., Ghaderi M., Tortoioli C., Falorni A., Santeusanio F., Brunetti P., Sanjeevi S.B., and Falorni A. Umbria type 1 Diabetes Registry: two distinct MICA gene markers discriminate major autoimmune diabetes types. J. Clin. Endocrinol. Metab. 86 (2001) 3754-3760
8. Gao X., Nelson G.W., Karacki P., Martin M.P., Phair J., Kaslow R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., O'Brien S.G., and Carrington M. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344 (2001) 1668-1675
9. Glyne P., and Price N. HLA and infectious diseases. In: Lechter R., and Warrens A. (Eds). HLA in Health and Disease (2000) 299-326
10. Gorodezky C., Aláez C., Vázquez-García M.N., de la Rosa G., Infante E., Balladares S., Toribio R., Pérez-Luque E., and Muñoz L. The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems and microsatellites. Hum. Immunol. 62 (2002) 979-991
11. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 10 (2002) 100-103
12. Halstead S. Pathogenesis of dengue: challenges to molecular biology. Science 23 (1998) 476-481
13. Halstead S., Streit T., Lafontant J., Putvatana R., Russell K., Sun W., Kanesa-Thasan N., Hayes C.G., and Watts D.M. Absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am. J. Trop. Med. Hyg. 65 (2001) 180-183
14. LaFleur C., Granados J., Vargas-Alarcón G., Ruiz-Morales J., Villarreal-Garza C., Higuera L., Hernandez-Pacheco G., Cutiño-Moguel T., Rangel H., Figueroa R., Acosta M., Lazcano E., and Ramos C. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum. Immunol. 63 (2002) 1039-1044
15. Laoprasopwattana K., Libraty D.H., Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., Reed G., Ennis F.A., Rothman A.L., and Green S. Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J. Infect. Dis. 192 (2005) 510-519
16. Leitmeyer K., Vaughn D., Watts D., Salas R., Villalobos I., Ramos C., and Ricco-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73 (1999) 4738-4747
17. Lisker R. Estructura genética de la población mexicana (1981), Salvat, México
18. Loke H., Bethell D.B., Phuong C.X., Dung M., Schneider J., White N.J., Day N.P., Farrar J., and Hill A. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?. J. Infect. Dis. 184 (2001) 1369-1373
19. Loke H., Bethell D., Phuong C., Day N., White N., Farrar J., and Hill A. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and FCγ receptor IIA genes. Am. J. Trop. Med. Hyg. 67 (2002) 102-106
20. Paradoa-Pérez M.L., Trujillo Y., and Lasanta P. Association of dengue hemorrhagic fever with HLA system. Haematologia (Budap) 20 (1987) 83-87
21. Perelygin A.A., Scherbik S.B., Zhulin I.B., Stockman B.M., Li Y., and Brinton M.A. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9322-9327
22. Polizel J.R., Bueno D., Visentainer J.E.L., Sell A.M., Borelli S.D., Tsuneto L.T., Machado O., Dalalio M., Coimbra M.T.M., and Moliterni R.A. Association of human leukocyte antigen DQ1 and dengue fever in a white southern Brazilian population. Mem. Inst. Oswaldo Cruz 99 (2004) 559-562
23. Rothman A., and Ennis F. Immunopathogenesis of dengue hemorrhagic fever. Virology 257 (1999) 1-6
24. Sakuntabhai A., Turbpaiboon C., Casadémont I., Chuansumrit A., Lowhnoo T., Kajaste-Rudnitski T., Kalayanarooj S.M., Tangnararatchakit K., Tangthawornchaikul N., Vasanawathana S., Chaiyaratana W., Yenchitsomanus P., Suriyaphol P., Avirutnan P., Chokephaibulkit K., Matsuda F., Yoksan S., Jakob Y., Lathrop G.M., Malasit P., Despres P., and Julier C. Variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37 (2005) 507-513
25. Serrano-Sánchez C. Mestizaje e historia de la población de México (con un esbozo antropológico de los lacandones de Chiapas). In: Martín Municio A., and García Barreno P. (Eds). Polimorfismo génico (HLA) en poblaciones hispanoamericanas (1996), Real Academia de Ciencias Exactas, Físicas y Naturales, Madrid
26. Sistema Único de Información para la Vigilancia Epidemiológica de Dengue. Dirección General de Epidemiología, Secretaría de Salud de México.
27. Stephens H., Klaythong R., Siriokong M., Vaughn D.W., Green S., Kalayanarooj S., Endy T.P., Libraty D.H., Nisalak A., Innis B.L., Rothman A.L., Ennis F.A., and Chandanayingyong D. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60 (2002) 309-318
28. Sverjgaard A., and Ryder L.P. HLA and disease associations: detecting the strongest association. Tissue Antigens 43 (1994) 18-27
29. Thomas D.C., and Witte J.S. Point: population stratification: a problem for case-control studies of candidate-gene associations?. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 505-512
30. Vader W., Stepeniak D., Kooy Y., Mearin L., Thompson A., Van Rood J., Spaenij L., and Koning F. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 12390-12395
31. Vaughn D., Green S., Kalayanarooj S., Innis B., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181 (2000) 2-9
32. World Health Organization. Dengue and Dengue Haemorrhagic Fever. WHO Fact Sheet (2008), WHO, Geneva
33. Yakub I., Lillibridge K.M., Moran A., Gonzalez O.Y., Belmont J., Gibbs R.A., and Tweardy D.J. Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylate synthetase and RNase L in patients hospitalized with West Nile Virus infection. J. Infect. Dis. 192 (2005) 1741-1748